Correlation Between Clal Biotechnology and BioLine RX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and BioLine RX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and BioLine RX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and BioLine RX, you can compare the effects of market volatilities on Clal Biotechnology and BioLine RX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of BioLine RX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and BioLine RX.

Diversification Opportunities for Clal Biotechnology and BioLine RX

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Clal and BioLine is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and BioLine RX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLine RX and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with BioLine RX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLine RX has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and BioLine RX go up and down completely randomly.

Pair Corralation between Clal Biotechnology and BioLine RX

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 0.21 times more return on investment than BioLine RX. However, Clal Biotechnology Industries is 4.73 times less risky than BioLine RX. It trades about -0.07 of its potential returns per unit of risk. BioLine RX is currently generating about -0.17 per unit of risk. If you would invest  3,780  in Clal Biotechnology Industries on September 3, 2024 and sell it today you would lose (100.00) from holding Clal Biotechnology Industries or give up 2.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  BioLine RX

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
BioLine RX 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLine RX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Clal Biotechnology and BioLine RX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and BioLine RX

The main advantage of trading using opposite Clal Biotechnology and BioLine RX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, BioLine RX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLine RX will offset losses from the drop in BioLine RX's long position.
The idea behind Clal Biotechnology Industries and BioLine RX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments